Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kang Yi

Showing results (241-250 of 256) with videos related to

Pageof 26
Sort By:
Oncotarget|July 25, 2016
Higher frequency but random distribution of EGFR mutation subtypes in familial lung cancer patientsKuo-Hsuan Hsu, Jeng-Sen Tseng, Chih-Liang Wang, et al.
Aging|July 16, 2021
BMI1 activates P-glycoprotein via transcription repression of <i>miR-3682-3p</i> and enhances chemoresistance of bladder cancer cellMing-Kun Chen, Jun-Hao Zhou, Peng Wang, et al.
Plos One|October 11, 2012
R26R-GR: a Cre-activable dual fluorescent protein reporter mouseYou-Tzung Chen, Ming-Shian Tsai, Tsung-Lin Yang, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|December 18, 2024
PD-L1 expression and immune profiling cannot predict osimertinib efficacy in lung cancer with EGFR T790 M mutation: A translational studyChing-Yao Yang, Wei-Yu Liao, Chao-Chi Ho, et al.
Nature Communications|June 29, 2026
Nur77 agonism invigorates Natural Killer cell immunity against hepatocellular carcinomaShi Yong Neo, Yu Mei, Joni Chong, et al.
Oncotarget|December 13, 2017
EGFR mutation, smoking, and gender in advanced lung adenocarcinomaChien-Hua Tseng, Chun-Ju Chiang, Jeng-Sen Tseng, et al.
Plos One|March 20, 2015
Identification of five driver gene mutations in patients with treatment-naïve lung adenocarcinoma in TaiwanKuo-Hsuan Hsu, Chao-Chi Ho, Te-Chun Hsia, et al.
Carcinogenesis|December 10, 2015
EGFR mutation and lobar location of lung adenocarcinomaChien-Hua Tseng, Kun-Chieh Chen, Kuo-Hsuan Hsu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 4, 2011
Clustered genomic alterations in chromosome 7p dictate outcomes and targeted treatment responses of lung adenocarcinoma with EGFR-activating mutationsShinsheng Yuan, Sung-Liang Yu, Hsuan-Yu Chen, et al.
Genome Research|June 22, 2013
Whole-genome sequencing identifies recurrent mutations in hepatocellular carcinomaZhengyan Kan, Hancheng Zheng, Xiao Liu, et al.
Pageof 26

Showing results (241-250 of 256) with videos related to

Sort By:
Pageof 26
Oncotarget|July 25, 2016
Higher frequency but random distribution of EGFR mutation subtypes in familial lung cancer patientsKuo-Hsuan Hsu, Jeng-Sen Tseng, Chih-Liang Wang, et al.
Aging|July 16, 2021
BMI1 activates P-glycoprotein via transcription repression of <i>miR-3682-3p</i> and enhances chemoresistance of bladder cancer cellMing-Kun Chen, Jun-Hao Zhou, Peng Wang, et al.
Plos One|October 11, 2012
R26R-GR: a Cre-activable dual fluorescent protein reporter mouseYou-Tzung Chen, Ming-Shian Tsai, Tsung-Lin Yang, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|December 18, 2024
PD-L1 expression and immune profiling cannot predict osimertinib efficacy in lung cancer with EGFR T790 M mutation: A translational studyChing-Yao Yang, Wei-Yu Liao, Chao-Chi Ho, et al.
Nature Communications|June 29, 2026
Nur77 agonism invigorates Natural Killer cell immunity against hepatocellular carcinomaShi Yong Neo, Yu Mei, Joni Chong, et al.
Oncotarget|December 13, 2017
EGFR mutation, smoking, and gender in advanced lung adenocarcinomaChien-Hua Tseng, Chun-Ju Chiang, Jeng-Sen Tseng, et al.
Plos One|March 20, 2015
Identification of five driver gene mutations in patients with treatment-naïve lung adenocarcinoma in TaiwanKuo-Hsuan Hsu, Chao-Chi Ho, Te-Chun Hsia, et al.
Carcinogenesis|December 10, 2015
EGFR mutation and lobar location of lung adenocarcinomaChien-Hua Tseng, Kun-Chieh Chen, Kuo-Hsuan Hsu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 4, 2011
Clustered genomic alterations in chromosome 7p dictate outcomes and targeted treatment responses of lung adenocarcinoma with EGFR-activating mutationsShinsheng Yuan, Sung-Liang Yu, Hsuan-Yu Chen, et al.
Genome Research|June 22, 2013
Whole-genome sequencing identifies recurrent mutations in hepatocellular carcinomaZhengyan Kan, Hancheng Zheng, Xiao Liu, et al.
Pageof 26